Evaluation and management of acute and recurrent UTIs

Dr. Suzette Sutherland shares her clinical strategy on the latest in UTI evaluation and management as incidence of drug resistant pathogens continues to rise and there are limited new antibiotics, creating a perfect storm for antibiotic resistance.

The 2019 AUA/CUA/SUFU Guidelines actually recommend using high quality PAC (Proanthocyanidins), which is 36 mg, as a strategic option to decrease urinary tract infections.

Efficacy depends on 3 things:

Dose: 36mg

Soluble: bioactive

A-type PAC: offers superior Anti-Adhesion Activity (AAA)

Complete the below form to access the webinar